Applied DNA Sciences, Inc. (APDN) Earning

NASDAQ Currency in USD Disclaimer

$0.18

south_east -$0.01 (-4.76%)
Day's range
$0.18
Day's range
$0.19

Applied DNA Sciences, Inc. Analyst EPS Estimates

Quarter Number of Estimates Low Estimate High Estimate Average Estimate
Q1 2024 1 -$4.50 -$4.50 -$4.50
Q2 2024 1 -$0.50 -$0.50 -$0.50
Q3 2024 1 -$0.34 -$0.34 -$0.34
Q4 2024 1 -$0.33 -$0.33 -$0.33
Q1 2025 1 -$0.28 -$0.28 -$0.28
Q2 2025 1 -$0.24 -$0.24 -$0.24
Q3 2025 1 -$0.23 -$0.23 -$0.23

Applied DNA Sciences, Inc. Earnings Date And Information

Applied DNA Sciences, Inc. last posted its earnings results on Tuesday, December 17th, 2024. The company reported $-0.32 earnings per share for the quarter, topping analysts' consensus estimates of $-0.33 by $0.01. The company had revenue of 797,519 for the quarter and had revenue of 3.43 M for the year. Applied DNA Sciences, Inc. has generated $-2 earnings per share over the last year ($-1.82 diluted earnings per share) and currently has a price-to-earnings ratio of -0.1. Applied DNA Sciences, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based on prior year's report dates.

Applied DNA Sciences, Inc. Earnings History by Quarter

Date Quarter Consensus Estimate Reported EPS Beat/Miss Revenue Estimate Actual Revenue
08/08/2024 Q3 2024 -$0.35 $0.47 0.82 $1.08 M $797,519
05/10/2024 Q2 2024 -$4.60 -$5.13 -0.53 $929,631
02/08/2024 Q1 2024 -$6.20 -$1.80 4.4 $891,164
01/26/2024 Q4 2023 -$5.29 $1.68 M $779,736
08/10/2023 Q3 2023 -$4.80 -$4.80 0 $2.56 M $2.92 M
05/11/2023 Q2 2023 -$3.40 $0.91 4.31 $4.41 M
02/09/2023 Q1 2023 -$6.60 -$6.00 0.6 $5.26 M
01/27/2023 Q4 2022 -$1.37 $4.10 M $3.56 M
08/11/2022 Q3 2022 -$7.20 -$0.13 7.07 $3.60 M $4.30 M
05/12/2022 Q2 2022 -$6.00 -$2.79 3.21 $6.15 M
02/10/2022 Q1 2022 -$3.80 -$12.61 -8.81 $4.17 M
01/28/2022 Q4 2021 -$12.04 $2.30 M $3.04 M
08/12/2021 Q3 2021 -$4.80 -$9.53 -4.73 $3.13 M $1.70 M
05/13/2021 Q2 2021 -$3.60 -$4.19 -0.59 $2.67 M
02/11/2021 Q1 2021 -$11.00 -$17.62 -6.62 $1.62 M
12/17/2020 Q4 2020 -$16.04 $707,500 $313,989
08/06/2020 Q3 2020 -$12.40 -$14.37 -1.97 $802,000 $431,516
05/14/2020 Q2 2020 -$0.77 -$15.71 -14.94 $552,473
02/06/2020 Q1 2020 -$1.24 -$22.37 -21.13 $633,519
01/27/2020 Q4 2019 -$23.00 $2.11 M $1.67 M
 

Applied DNA Sciences, Inc. Earnings: FAQ's

When is Applied DNA Sciences, Inc.'s earnings date?

Applied DNA Sciences, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, February 6th, 2025 based off last year's report dates.

Did Applied DNA Sciences, Inc. beat their earnings estimates last quarter?

In the previous quarter, Applied DNA Sciences, Inc. (:APDN) reported $-0.32 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.33 by $0.01.

How can I listen to Applied DNA Sciences, Inc.'s earnings conference call?

The conference call for Applied DNA Sciences, Inc.'s latest earnings report can be listened to online.

How can I read Applied DNA Sciences, Inc.'s conference call transcript?

The conference call transcript for Applied DNA Sciences, Inc.'s latest earnings report can be read online.

How much revenue does Applied DNA Sciences, Inc. generate each year?

Applied DNA Sciences, Inc. (:APDN) has a recorded annual revenue of $3.43 M.

How much profit does Applied DNA Sciences, Inc. generate each year?

Applied DNA Sciences, Inc. (:APDN) has a recorded net income of $3.43 M. Applied DNA Sciences, Inc. has generated $-1.82 earnings per share over the last four quarters.

What is Applied DNA Sciences, Inc.'s price-to-earnings ratio?

Applied DNA Sciences, Inc. (:APDN) has a price-to-earnings ratio of -0.1 and price/earnings-to-growth ratio is -0.

Portfolio Sync
Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED